The mechanics to confirm before you commit to volume
A direct-compounder pricing relationship raises specific questions a clinic should resolve before signing. Ask whether your rate is tied to a minimum monthly order volume, what happens if you fall short, and whether better rates require a longer-term commitment. Ask whether the rate is per formulation or whether ordering multiple SKUs (testosterone, semaglutide, a peptide compound) is treated differently than ordering a single high-volume product. And ask whether rates reset or adjust over time, because a launch rate that changes later affects margin you already built patient pricing around.
The harder issue with any unpublished pricing model is verification. Without public tiers, you cannot independently confirm whether the rate you receive reflects the volume and formulation mix you bring. That is not a reason to dismiss the model — a direct compounder relationship can genuinely deliver strong rates on specific SKUs — but it is a reason to get the cost structure in writing for your specific formulary rather than relying on a general commitment.